JP2014532407A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532407A5
JP2014532407A5 JP2014538879A JP2014538879A JP2014532407A5 JP 2014532407 A5 JP2014532407 A5 JP 2014532407A5 JP 2014538879 A JP2014538879 A JP 2014538879A JP 2014538879 A JP2014538879 A JP 2014538879A JP 2014532407 A5 JP2014532407 A5 JP 2014532407A5
Authority
JP
Japan
Prior art keywords
cancer
leukemia
lymphoma
seq
braf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014538879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532407A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/061501 external-priority patent/WO2013062976A1/en
Publication of JP2014532407A publication Critical patent/JP2014532407A/ja
Publication of JP2014532407A5 publication Critical patent/JP2014532407A5/ja
Pending legal-status Critical Current

Links

JP2014538879A 2011-10-24 2012-10-23 がんにおけるbraf変異を検出する方法 Pending JP2014532407A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550504P 2011-10-24 2011-10-24
US61/550,504 2011-10-24
PCT/US2012/061501 WO2013062976A1 (en) 2011-10-24 2012-10-23 Methods of detecting braf mutations in cancer

Publications (2)

Publication Number Publication Date
JP2014532407A JP2014532407A (ja) 2014-12-08
JP2014532407A5 true JP2014532407A5 (enExample) 2015-12-10

Family

ID=47138195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014538879A Pending JP2014532407A (ja) 2011-10-24 2012-10-23 がんにおけるbraf変異を検出する方法

Country Status (6)

Country Link
US (1) US20130130264A1 (enExample)
EP (1) EP2771486A1 (enExample)
JP (1) JP2014532407A (enExample)
AU (1) AU2012329042A1 (enExample)
CA (1) CA2865037A1 (enExample)
WO (1) WO2013062976A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012253525B2 (en) * 2011-05-10 2016-09-22 Brunangelo Falini Hairy cell leukemia biomarkers and methods of using same
CA2926722A1 (en) * 2013-10-19 2015-04-23 Trovagene, Inc. Detecting mutations in disease over time
WO2015058175A2 (en) * 2013-10-19 2015-04-23 Trovagene, Inc. Detecting and monitoring mutations in histiocytosis
CA2954689A1 (en) * 2014-07-11 2016-01-14 Expression Pathology, Inc. Srm/mrm assay for the serine/threonine-protein kinase b-raf (braf)
CN106755489A (zh) * 2017-01-22 2017-05-31 杭州金溪生物技术有限公司 高灵敏度基因突变检测方法及所用试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020657A1 (en) * 2005-05-20 2007-01-25 Grebe Stefan K Methods for detecting circulating tumor cells
WO2007106534A2 (en) * 2006-03-14 2007-09-20 Harbor-Ucla Research And Education Institute Selective amplification of minority mutations using primer blocking high-affinity oligonucleotides
EP2337865B1 (en) * 2008-10-20 2014-11-19 Roche Diagnostics GmbH Allele-specific amplification using a primer with a modified nucleotide
AU2012253525B2 (en) * 2011-05-10 2016-09-22 Brunangelo Falini Hairy cell leukemia biomarkers and methods of using same

Similar Documents

Publication Publication Date Title
US12054786B2 (en) Methods for detecting CpG methylation and for diagnosing cancer
Boer et al. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside
JP2014532407A5 (enExample)
Lecomte et al. Circulating free tumor DNA and colorectal cancer
JP2015091235A5 (enExample)
KR20150054633A (ko) 클램핑 프로브 및 검출 프로브를 이용한 다중 표적핵산 검출방법
WO2019035100A2 (en) PROGNOSTIC MARKERS OF CANCER RECIDIVE
CN107502654A (zh) 用于实体瘤靶向用药指导的多基因富集和检测方法
Kang et al. FAS− 1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer
Taenzer et al. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma
CN102796817A (zh) 一种快速检测kras基因突变的方法
Yu et al. High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers
WO2006084051A3 (en) Use of id4 for diagnosis and treatment of cancer
Zafar et al. Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives
CN102399862A (zh) 一种基于解链曲线的甲基化dna检测方法
CN109072290A (zh) 用于检测基因突变的方法
RU2014126098A (ru) МУТАЦИИ ErbB3 ПРИ РАКЕ
WO2017045689A1 (en) Methods and materials for detection of mutations
JP2015500638A5 (enExample)
MX2007008984A (es) Marcadores de cancer y metodos de deteccion.
Choi et al. Prognostic impact of polymorphisms in the CASPASE genes on survival of patients with colorectal cancer
Li et al. A single-nucleotide polymorphism of miR-196a2T> C rs11614913 is associated with hepatocellular carcinoma in the Chinese population
CN104087674B (zh) 一种人表皮生长因子受体突变基因检测试剂盒
Naidu et al. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development
WO2020130944A1 (en) Method of diagnosing gastric cancers using micrornas